| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| (Un)conventional combinations: At the origins of breakthrough inventions |
1 |
1 |
1 |
12 |
1 |
1 |
2 |
44 |
| A Comparison of U.S. And European University-Industry Relations in the Life Sciences |
0 |
0 |
0 |
0 |
0 |
1 |
5 |
394 |
| A Comparison of U.S. and European University-Industry Relations in the Life Sciences |
0 |
0 |
0 |
65 |
0 |
1 |
3 |
343 |
| A Few Special Cases: Scientific Creativity and Network Dynamics in the Field of Rare Diseases |
0 |
0 |
0 |
24 |
0 |
0 |
1 |
160 |
| A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
80 |
| A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence |
0 |
0 |
0 |
4 |
1 |
1 |
1 |
41 |
| A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment |
0 |
0 |
0 |
5 |
0 |
1 |
3 |
85 |
| A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
65 |
| A Trick of the (Pareto) Tail |
0 |
0 |
0 |
54 |
0 |
3 |
4 |
193 |
| An extreme value analysis of the last century crises across industries in the U.S. economy |
0 |
0 |
0 |
13 |
0 |
0 |
2 |
59 |
| Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks |
0 |
0 |
1 |
24 |
0 |
0 |
2 |
145 |
| Biomedical Innovation Clusters |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
31 |
| Brain-Circulation Network: The Global Mobility of the Life Scientists |
0 |
1 |
7 |
100 |
0 |
2 |
22 |
259 |
| Cluster analysis of weighted bipartite networks: a new copula-based approach |
0 |
0 |
0 |
53 |
0 |
0 |
0 |
52 |
| Co-evolution of Organizational Forms and Technology |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
249 |
| Co-experience Network Dynamics: Lessons from the Dance Floor |
0 |
0 |
0 |
25 |
1 |
1 |
1 |
74 |
| Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry |
0 |
0 |
0 |
234 |
0 |
0 |
0 |
457 |
| Crescita proporzionale e politiche pubbliche: proposte per una sintesi evolutiva |
0 |
0 |
0 |
19 |
0 |
0 |
3 |
117 |
| Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali |
0 |
0 |
0 |
13 |
0 |
0 |
1 |
86 |
| Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure |
0 |
0 |
1 |
150 |
0 |
0 |
2 |
513 |
| From La Bohème to La Wally: How Organizational Status Affects the (Un)conventionality of Opera Repertoires |
0 |
0 |
0 |
7 |
0 |
0 |
0 |
51 |
| Global Networks of Trade and Bits |
0 |
0 |
0 |
55 |
0 |
1 |
1 |
135 |
| Global Value Trees |
0 |
0 |
0 |
11 |
0 |
0 |
0 |
28 |
| Global Virtual Water Trade: Integrating Structural Decomposition Analysis with Network Theory |
0 |
0 |
0 |
48 |
0 |
0 |
2 |
75 |
| Global Virtual Water Trade: integrating Structural Decomposition Analysis with Network Theory |
0 |
0 |
0 |
37 |
0 |
0 |
0 |
72 |
| Global value trees |
0 |
0 |
0 |
65 |
0 |
0 |
0 |
49 |
| Homophily and Triadic Closure in Evolving Social Networks |
0 |
0 |
0 |
60 |
0 |
1 |
4 |
99 |
| I Farmaci Oncologici in Italia: innovazione e sostenibilità economica |
0 |
0 |
1 |
54 |
0 |
0 |
5 |
236 |
| Identifying Geographic Clusters: A Network Analytic Approach |
0 |
0 |
0 |
56 |
1 |
1 |
1 |
63 |
| Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato |
0 |
0 |
0 |
14 |
0 |
0 |
0 |
113 |
| Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico |
0 |
0 |
0 |
23 |
0 |
1 |
1 |
142 |
| Innovation and Corporate Dynamics: A Theoretical Framework |
0 |
0 |
0 |
151 |
1 |
1 |
2 |
261 |
| Innovation and Corporate Dynamics: A Theoretical Framework |
0 |
0 |
0 |
67 |
0 |
0 |
2 |
129 |
| Innovation and Corporate Growth in the Evolution of the Drug Industry |
0 |
0 |
1 |
431 |
0 |
1 |
5 |
983 |
| Innovation, trade and the size of exporting firms |
0 |
0 |
0 |
42 |
0 |
0 |
1 |
71 |
| Is There a Productivity Crisis in Pharmaceutical R&D? |
0 |
0 |
1 |
12 |
0 |
1 |
4 |
61 |
| La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale |
0 |
0 |
1 |
16 |
0 |
1 |
2 |
120 |
| Market Structure and Drug Innovation |
0 |
0 |
0 |
30 |
1 |
2 |
6 |
144 |
| Medical Devices Competitiveness and Impact on Public Health Expenditure |
0 |
0 |
1 |
190 |
0 |
2 |
13 |
782 |
| Medical Devices: Competitiveness and Impact on Public Health Expenditure |
0 |
0 |
0 |
33 |
0 |
1 |
3 |
179 |
| Missing Links in Multiple Trade Networks |
0 |
0 |
0 |
23 |
0 |
0 |
2 |
58 |
| Monthly Report No. 03/2020 |
0 |
0 |
0 |
4 |
0 |
0 |
5 |
36 |
| Networks Dynamics in the Pharmaceutical Industry |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
254 |
| Networks of innovators within and across borders. Evidence from patent data |
0 |
0 |
0 |
114 |
1 |
3 |
5 |
248 |
| Nuove politiche per l'innovazione nel settore delle scienze della vita |
0 |
0 |
1 |
7 |
0 |
0 |
1 |
97 |
| On Firm Growth in Networks |
0 |
0 |
0 |
20 |
1 |
1 |
1 |
113 |
| On Size and Growth of Business Firms |
0 |
0 |
0 |
35 |
0 |
0 |
4 |
340 |
| Pareto versus lognormal: a maximum entropy test |
0 |
0 |
2 |
98 |
0 |
0 |
4 |
204 |
| Patent Disclosure and R&D Competition in Pharmaceuticals |
0 |
0 |
0 |
117 |
0 |
0 |
4 |
322 |
| Patent Disclosure and R&D Competition in Pharmaceuticals |
0 |
0 |
0 |
110 |
0 |
2 |
3 |
196 |
| Patent Value and R&D Competition |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
106 |
| Preferential attachment and growth dynamics in complex systems |
0 |
0 |
0 |
19 |
0 |
1 |
2 |
115 |
| Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals |
0 |
0 |
0 |
251 |
0 |
0 |
1 |
524 |
| Quali Regole per la Spesa Farmaceutica? - Criticità, Impatti, Proposte |
0 |
0 |
1 |
11 |
0 |
2 |
5 |
59 |
| Radical Innovation and Network Evolution |
0 |
0 |
0 |
142 |
0 |
0 |
0 |
345 |
| Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica |
0 |
0 |
0 |
16 |
0 |
1 |
2 |
115 |
| Statistical Properties of Business Firms Structure and Growth |
0 |
1 |
1 |
19 |
1 |
3 |
4 |
88 |
| Stochastic Trade Networks |
0 |
0 |
0 |
30 |
1 |
2 |
3 |
98 |
| Stochastic Trade Networks |
0 |
0 |
0 |
91 |
0 |
1 |
4 |
205 |
| Structure of Business Firm Networks and Scale-Free Models |
0 |
0 |
0 |
11 |
0 |
0 |
0 |
95 |
| Structure of Business Firm Networks and Scale-Free Models |
0 |
0 |
0 |
53 |
0 |
0 |
1 |
238 |
| Systemic importance of financial institutions: from a global to a local perspective? A network theory approach |
0 |
0 |
0 |
93 |
0 |
0 |
1 |
133 |
| Systemic importance of financial institutions: regulations, research, open issues, proposals |
0 |
0 |
0 |
50 |
0 |
0 |
0 |
204 |
| Systemic risk and banking regulation: some facts on the new regulatory framework |
0 |
0 |
0 |
137 |
0 |
0 |
0 |
223 |
| Talents from Abroad. Foreign Managers and Productivity in the United Kingdom |
0 |
0 |
0 |
54 |
3 |
5 |
8 |
70 |
| Technological Regimes and the Growth of Networks An Empirical Analysis |
0 |
0 |
0 |
129 |
0 |
0 |
0 |
356 |
| The Global Health Networks: A Comparative Analysis of Tuberculosis, Malaria and Pneumonia Using Social Media Data |
0 |
0 |
0 |
76 |
0 |
1 |
5 |
109 |
| The Growth of Business Firms: Theoretical Framework and Empirical Evidence |
0 |
0 |
1 |
169 |
0 |
1 |
2 |
1,659 |
| The Growth of Business Firms: Theoretical Framework and Empirical Evidence |
0 |
0 |
0 |
21 |
0 |
1 |
2 |
123 |
| The Indirect Effects of FDI on Trade: A Network Perspective |
1 |
1 |
1 |
48 |
3 |
4 |
7 |
109 |
| The Indirect Effects of FDI on Trade: A Network Perspective |
0 |
0 |
0 |
38 |
0 |
1 |
1 |
40 |
| The Nature and the Extent of the Market for Technology in Biopharmaceuticals |
0 |
0 |
0 |
47 |
0 |
0 |
1 |
187 |
| The Network of U.S. Mutual Fund Investments: Diversification, Similarity and Fragility throughout the Global Financial Crisis |
0 |
0 |
2 |
23 |
0 |
2 |
6 |
43 |
| The Relation Between Global Migration and Trade Networks |
0 |
0 |
0 |
20 |
0 |
0 |
1 |
69 |
| The Relation Between Global Migration and Trade Networks |
0 |
0 |
0 |
49 |
0 |
1 |
4 |
125 |
| The Similarity of Global Value Chains: A Network-Based Measure |
0 |
0 |
0 |
56 |
0 |
0 |
1 |
143 |
| The Similarity of Global Value Chains: A Network-Based Measure |
1 |
1 |
2 |
47 |
1 |
2 |
6 |
114 |
| The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
0 |
37 |
0 |
0 |
2 |
103 |
| The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
0 |
28 |
0 |
0 |
1 |
80 |
| The Size Variance Relationship of Business Firm Growth Rates |
0 |
0 |
0 |
33 |
0 |
0 |
1 |
93 |
| The Structure and Growth of International Trade |
0 |
0 |
1 |
106 |
0 |
0 |
1 |
222 |
| The Structure and Growth of International Trade |
0 |
0 |
0 |
24 |
0 |
0 |
12 |
162 |
| The Structure and Growth of International Trade |
0 |
0 |
0 |
68 |
0 |
0 |
0 |
239 |
| The Structure and Growth of Weighted Networks |
0 |
0 |
0 |
63 |
0 |
0 |
0 |
157 |
| The Structure and Growth of World Trade, and the Role of Europe in the Global Economy |
0 |
0 |
1 |
38 |
0 |
1 |
3 |
96 |
| The Sustainability of European Health Care Systems: Beyond Income and Ageing |
0 |
0 |
0 |
3 |
0 |
0 |
1 |
46 |
| The Sustainability of European Health Care Systems: Beyond Income and Ageing |
0 |
0 |
1 |
59 |
0 |
1 |
2 |
200 |
| The Value of Failures in Pharmaceutical R&D |
0 |
0 |
0 |
33 |
0 |
0 |
2 |
149 |
| The evolution of networks of innovators within and across borders: Evidence from patent data |
0 |
0 |
0 |
149 |
1 |
2 |
10 |
232 |
| The migration network effect on international trade |
0 |
0 |
0 |
120 |
0 |
1 |
1 |
184 |
| The productivity crisis in pharmaceutical R&D |
0 |
1 |
1 |
180 |
3 |
5 |
8 |
516 |
| The rise of China in the international trade network: a community core detection approach |
0 |
0 |
0 |
37 |
0 |
1 |
2 |
81 |
| Virtual Water Trade and Bilateral Conflicts |
0 |
0 |
1 |
33 |
0 |
0 |
3 |
70 |
| Where Gibrat meets Zipf: Scale and Scope of French Firms |
0 |
0 |
0 |
50 |
0 |
1 |
2 |
116 |
| World Input-Output Network |
0 |
0 |
0 |
53 |
0 |
0 |
1 |
63 |
| World Input-Output Network |
0 |
0 |
0 |
139 |
0 |
1 |
1 |
129 |
| Total Working Papers |
3 |
6 |
31 |
5,702 |
21 |
71 |
254 |
17,741 |
LogEc is hosted by the
Örebro University School of Business.